NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $10,451,000 | +36.4% | 292,180 | -0.9% | 0.01% | +27.3% |
| Q3 2014 | $7,663,000 | -20.9% | 294,728 | +0.5% | 0.01% | -15.4% |
| Q2 2014 | $9,689,000 | +7.8% | 293,158 | -2.4% | 0.01% | 0.0% |
| Q1 2014 | $8,986,000 | -0.8% | 300,239 | +0.6% | 0.01% | 0.0% |
| Q4 2013 | $9,058,000 | -7.0% | 298,337 | -2.5% | 0.01% | -18.8% |
| Q3 2013 | $9,735,000 | +119.2% | 306,041 | +4.1% | 0.02% | +100.0% |
| Q2 2013 | $4,442,000 | – | 293,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 431,525 | $11,219,000 | 4.40% |
| Palo Alto Investors LP | 1,699,562 | $44,189,000 | 3.30% |
| FCG ADVISORS, LLC | 133,504 | $4,116,000 | 2.71% |
| SECTORAL ASSET MANAGEMENT INC | 1,726,824 | $44,897,000 | 1.89% |
| Rhenman & Partners Asset Management AB | 224,000 | $5,824,000 | 1.70% |
| BENDER ROBERT & ASSOCIATES | 75,090 | $1,952,000 | 1.36% |
| Penn Capital Management Company, LLC | 1,035,144 | $26,914,000 | 1.12% |
| NEXT CENTURY GROWTH INVESTORS LLC | 1,066,148 | $27,719,000 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 391,281 | $10,173,000 | 0.98% |
| SCHOLTZ & COMPANY, LLC | 31,990 | $832,000 | 0.82% |